Marker Therapeutics Inc. logo

Marker Therapeutics Inc.

MRKR | NASDAQ
Chart Builder DCF Calculator
$1.20
+$0.02 (+1.69%)
At close: Sep 21, 2026, 4:00 PM ET
$1.20
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$19.67M
Enterprise Value
$8.68M
Beta
1.53
Average Volume
64.78K
Shares Outstanding (Diluted)
19.31M
Shares Change YoY
38.39%
Institutional Ownership
20.21%
Exchange
NASDAQ
ISIN
US57055L2060

Price Performance

Price Change 1M
-16.7%
Price Change 3M
-12.4%
Price Change 6M
-10.4%
Price Change YTD
-22.1%
Price Change 1Y
33.3%
Price Change 3Y
-75.7%
Price Change 5Y
-93.3%
1M CAGR (ann.)
5.4%
1Y CAGR (ann.)
24.2%
5Y CAGR (ann.)
-42.6%
All-Time CAGR
-44.9%

Valuation

PE Ratio
-2.55
Forward PE
N/A
PEG Ratio
-0.02
Forward PEG
-0.05
PS Ratio
16.23
Forward PS
1.00
PB Ratio
1.64
P/FCF Ratio
-2.05
P/Adj. FCF Ratio
-1.95
P/OCF Ratio
-2.35
EV/Sales
7.04
EV/EBIT
-1.26
EV/EBITDA
-0.91
EV/FCF
-0.89
Earnings Yield
-39.2%
FCF Yield
-48.8%
Adj. FCF Yield
-51.4%

Financial Health

Net Cash
$11.33M
Total Debt
$0
Cash & Short-Term Investments
$11.33M
Total Assets
$14.59M
Current Ratio
6.03
Quick Ratio
6.03
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-40.15
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
-320.8%
Operating Profit Margin
-869.0%
EBITDA Margin
-707.5%
Net Profit Margin
-706.2%
FCF Margin
-791.3%
Adj. FCF Margin
-833.4%
SBC / Revenue
27.6%
SBC Impact (per share)
-5.3%

Returns

Return on Assets
-59.7%
Return on Equity
-57.0%
Return on Invested Capital
-87.9%
Return on Capital Employed
-88.1%
Return on Tangible Assets
-59.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
-31.0%
Revenue CAGR 5Y
-5.5%
Revenue CAGR 10Y
25.7%
EPS CAGR 3Y
34.9%
EPS CAGR 5Y
48.2%
EPS CAGR 10Y
26.8%
FCF CAGR 3Y
5.4%
FCF CAGR 5Y
32.1%
FCF CAGR 10Y
0.3%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
166.7%
Revenue Growth Next 3Y
411.1%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-9.76M
Free Cash Flow
$-9.76M
Adj. Free Cash Flow
$-10.28M
FCF Per Share
-$0.51
OCF Per Share
-$0.51
OCF/S Ratio
-791.3%

Income Statement

Revenue
$1.23M
Gross Profit
$-3.96M
Operating Income
$-10.71M
EBITDA
$-9.52M
Net Income
$-8.71M
EPS (Diluted)
-$0.47
Revenue / Employee
$246.59K
Profit / Employee
$-1.74M
Employees
5

© 2026 bestshares.com. All rights reserved.